US CDC OKs use of new Pfizer, GSK vaccines for RSV in older adults

US CDC OKs use of new Pfizer, GSK vaccines for RSV in older adults The director of the U.S. Centers for Disease Control and Prevention on Thursday signed off on the use of new vaccines from Pfizer and GSK to prevent severe respiratory syncytial virus (RSV) infections in older adults. Reuters Reuters

...

DC Director Rochelle Walensky endorsed agency advisers' recommendation that adults aged 60 or older get the shots, but stopped short of saying all of that population should get one of the vaccines.

...